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Abstract 31 
Since 1960, the European eel (Anguilla anguilla) has suffered a dramatic reduction in 32 
natural stocks. Breeding in captivity is considered an alternative, but obtaining high 33 
quality sperm seems basic on this regard. The main objective of this study was to assess 34 
the effects of three thermal regimes (two of them variable: T10 and T15; and one of 35 
them constant: T20) and three hormonal treatments with different hormones (hCG, 36 
hCGrec and PSMG) on the induction of maturation in European eel males.  37 
In the case of the thermal regimes, our results demonstrated that the onset and 38 
progression of spermiation are strongly influenced, and perhaps closely regulated, by 39 
water temperature. T20 demonstrated the best results in all the sperm parameters 40 
(volume, density, motility, kinetic features, etc) throughout most weeks of treatment, 41 
becoming a reliable and productive method for inducing spermiation in this species. In 42 
the case of hormonal treatments, the onset and progression of spermiation in European 43 
eel males were influenced by the hormone used. In this respect, hCGrec produced the 44 
best results in all the sperm parameters including volume, density, motility, kinetic 45 
features, etc., throughout most weeks of treatment, thus becoming an effective 46 
alternative treatment to the standard hCG treatment used to induce spermiation in eel 47 
species. Moreover, hCGrec gave rise to the best economical profitability, making it 48 
possible to obtain good quality sperm samples at a lower price than by using the other 49 
two hormonal treatments. 50 
 51 
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1. Introduction 54 
The European eel (Anguilla anguilla) is a teleost fish with a peculiar life cycle: 55 
prepubertal eels migrate across the Atlantic Ocean for supposedly 6–7 months to reach 56 
the spawning area, in the Sargasso Sea (Tesch, 1978; Van Ginneken and Maes, 2005). 57 
In the last years the European eel has suffered a dramatic reduction in its population 58 
mainly due to varying factors including overfishing, habitat reduction and 59 
contamination (Feunteun, 2002). Therefore, breeding in captivity is the only alternative 60 
to save this species, reducing the pressure on natural populations, and meeting the 61 
demands of eel farms. 62 
A good tool for a breeding captivity program is obtaining high quality sperm during a 63 
large number of weeks with the aim of synchronizing the gametes maturation and 64 
fertilizing the ova produced throughout the breeding season (Jorstad and Navdal, 1996; 65 
Roldan and Gomendio, 2009). 66 
In some fish species, reproduction in captivity can be controlled exclusively by 67 
environmental factors such as temperature, photoperiod or salinity. However, 68 
sometimes it is impractical or even impossible to simulate the environmental factors of 69 
the breeding process (i.e., spawning migration, depth, pressure, etc.) so the use of 70 
exogenous hormones is the only effective way of inducing maturation and spermiation 71 
(Boetius and Boetius, 1967; Ohta et al., 1996; Pérez et al., 2000; Asturiano et al., 2006 ; 72 
Kagawa et al., 2009;). Eels (Anguilla spp.) do not mature spontaneously in captivity, so 73 
the maturation of males must be induced with long-term hormonal treatments 74 
(Asturiano et al., 2005; Huang et al., 2009; Ohta et al., 1997; Pérez et al., 2000). 75 
However, in several studies has been described that the sexual maturation of non-treated 76 
males could be stimulated indirectly by treated males, suggesting the existence of 77 
chemical communication (pheromones) between them (Huertas et al., 2006). Despite 78 
the effectiveness of these long-term hormonal treatments, little attention has been paid 79 
to factors such as the duration of spermiation periods, which has been limited in time, or 80 
the variations in sperm quality parameters (Asturiano et al., 2005; Miranda et al., 2005; 81 
Mylonas et al., 1998).  82 
A high number of environmental and procedural factors can affect the gonadal 83 
development and, consequently, the gamete quality (Mylonas et al., 2010). With regards 84 
to environmental factors, the water temperature plays a key role in the gonadal 85 
development in many fish species (García-López et al., 2006; Lim et al., 2003; Van Der 86 
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Kraak and Pankhurst, 1997). In the case of the European eel, the temperature of the 87 
hypothetical spawning area is around 20 ºC (Boetius and Boetius, 1967), and this is 88 
probably the reason why both males and females of this species have been matured at 89 
this constant water temperature (Asturiano et al., 2002, 2006; Pedersen, 2003; Pérez et 90 
al., 2000). However, it has been reported that eels undertake vertical movements during 91 
their migration across deep and cold waters (Aarestrup et al., 2009), so it seems 92 
probable that the gonadal development, that takes several months, occurs at low 93 
temperatures, and the spawning at warm temperatures. Recently it has been shown that 94 
in female European eel, variable thermal regimes induce hormonal profiles that 95 
resemble the natural ones more closely than those obtained under constant temperatures 96 
(Pérez et al., 2011). 97 
Regarding procedural factors, both the type and dosage of hormone used are key factors 98 
in the artificial maturation of aquaculture species. Hormonal methods have evolved over 99 
time, from the use of pituitaries from mature fish to the use of various synthetic agonists 100 
of different hormones (Billard and Marcel, 1980; Rosenfeld et al., 2012; Yaron, 1995). 101 
Human chorionic gonadotropin (hCG) has been the hormone most widely used in the 102 
maturation and spermiation process in the European eel. However, due to 103 
recent problems in the availability of this hormone, new hormones should be tested. In 104 
this respect, recombinant hCG (hCGrec), produced by recombinant DNA technology 105 
(Satish, 1989), could be a good alternative because it has a similar structure 106 
to the native hormone. On the other hand, pregnant mare's serum gonadotropin (PMSG), 107 
which is a priori a cheaper choice than hCG and hCGrec hormones, has already been 108 
used in other fish species (Brzuska and Ryszka, 1990; Nagahama, 1994; Zakes and 109 
Demska-Zakes, 2009) to induce both spermiation and ovulation. Therefore, PMSG can 110 
be considered as another option for its use in reproduction studies for eel aquaculture. 111 
Nowadays, the weekly administration of hCG under a constant temperature regime of 112 
20 ºC (Asturiano et al., 2005; Peñaranda et al., 2010b; Pérez et al., 2000) has been the 113 
most widely used hormonal treatment in European eel males. Despite the good results 114 
obtained by this method, the number of weeks in which eels produce a high volume of 115 
good sperm is limited, and as such more evolved treatments are necessary to achieve 116 
shorter induction times, longer spermiation periods and/or higher volumes of quality 117 
sperm. Therefore, the study of alternative hormonal treatments must be an ongoing 118 
task in order to improve the current methods to date. In this respect, the aim of this trial 119 
was to assess the effect of the thermal regime (3 thermal regimes, including the standard 120 
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constant treatment of 20ºC), and the kind of hormone used (3 hormonal treatments, 121 
including the standard hCG treatment) on the reproductive performance of European eel 122 
males. 123 
 124 
2. Materials and methods 125 
2.1 Fish maintenance  126 
Eel males from the fish farm Valenciana de Acuicultura, S.A. (Puzol, Valencia; East 127 
coast of Spain) were moved to our facilities, in the Aquaculture Laboratory at the 128 
Universitat Politècnica de València, Spain. The fish were distributed in 129 
aquaria equipped with separate recirculation systems, thermostats/coolers (to control the 130 
water temperature in the first experiment) and covered to maintain constant darkness. 131 
The eels were gradually acclimatized to sea water over the course of one week (salinity 132 
37 ± 0.3 g/l), and once a week they were anaesthetized with benzocaine (60 ppm) and 133 
weighed before receiving the administration of hormones by intraperitoneal injection. 134 
The fish were not fed throughout the experiment and were handled in accordance with 135 
the European Union regulations concerning the protection of experimental animals (Dir 136 
86/609/EEC). 137 
 138 
2.2 Thermal treatments 139 
A total of 317 adult male eels (mean body weight 100±2 g) were equally and randomly 140 
distributed in six 200-L aquaria (approximately 100 males per treatment) and subjected 141 
to three thermal regimes: T10, 10 ºC (first 6 weeks), 15 ºC (next 3 weeks) and 20 ºC 142 
(last 6 weeks); T15, 15 ºC (first 6 weeks) and 20 ºC (last 9 weeks); and T20, 20 ºC 143 
during the whole experimental period (Figure 1). 144 
All the males were hormonally treated for the induction of maturation and spermiation 145 
with weekly intraperitoneal injections of human chorionic gonadotropin (hCG; 1.5 IU g-146 
1 fish; Argent Chemical Laboratories. USA) during 13 weeks. 147 
 148 
2.3 Hormonal treatments 149 
In a second experiment, and after choosing the best thermal regime (T20), a total of 54 150 
adult male eels (mean body weight 81±7 g) were equally and randomly distributed in 151 
three 200-L aquaria (18 males per treatment) and submitted to three hormonal 152 
treatments: hCG, hCGrec (recombinant hCG; Ovitrelle. Madrid) and PSMG (pregnant 153 
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mare's serum gonadotropin; Sincropart, Lab CEVA. Barcelona). All hormones were 154 
diluted 1:1 (UI/µl) in saline solution (NaCl 0.9 %) and a weekly dose of 1.5 IU g-1 155 
fish was administered during 20 weeks. 156 
 157 
2.4 Sperm collection and sampling 158 
Sperm samples were collected 24 h after the administration of the hormone because 159 
previous studies (Pérez et al., 2000) have demonstrated that this is when the highest 160 
sperm quality is found. For the sperm collection the fish were anesthetized and after 161 
cleaning the genital area with freshwater and thoroughly drying to avoid the 162 
contamination of the samples with faeces, urine and sea water, the sperm were collected 163 
by abdominal pressure. A small aquarium air pump was modified to obtain a vacuum 164 
breathing force and to collect the sperm in a tube. A new tube was used for every male 165 
and distilled water was used to clean the collecting pipette between the different males.  166 
To measure sperm density, samples were diluted 1:1000 or 1:10000 in P1 medium (in 167 
mM: NaCl 125, NaHCO3 20, KCl 30, MgCl2 2.5, CaCl2 1, pH 8.5; Asturiano et al., 168 
2004a). Ten microlitres of the dilution were taken for counting in a Thoma 169 
haemocytometer and expressed as spermatozoa x109 ml-1. Sperm volume was measured 170 
using graduated tubes and samples were maintained at 4 ºC until analysis and were 171 
evaluated in the first hour after extraction. 172 
 173 
2.5 Evaluation of motility and kinetic sperm parameters 174 
Sperm was activated by mixing 2 µl of sperm with 200 µl of artificial sea water (Aqua 175 
Medic Meersalz, 37 g/l, with 2% BSA (w/v), pH adjusted to 8.2; Peñaranda et al., 176 
2010c). All the motility analyses were performed by triplicate at 30s post-activation by 177 
the motility module of ISAS (Proiser R+D, S.L.; Paterna, España) using an ISAS® 178 
782M camera recorder (60 fps; Hz). The chamber used in all experiments was a 179 
SpermTrack-10® (Proiser, Paterna, Spain) with 10x negative contrast phase lens in a 180 
Nikon Eclipse (E-400) microscope. 181 
The parameters considered in this study were total motility (MOT, %); progressive 182 
motility (P-MOT, %), defined as the percentage of spermatozoa which swim forwards 183 
in 80% of a straight line; curvilinear velocity (VCL, in µm/s), defined as the 184 
time/average velocity of a sperm head along its actual curvilinear trajectory; average 185 
path velocity (VAP, µm/s), defined as the time/average of sperm head along its spatial 186 
average trajectory; and straight line velocity (VSL, µm/s), defined as the time/average 187 
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velocity of a sperm head along the straight line between its first detected position and its 188 
last position. Spermatozoa were considered motile if their progressive motility had 189 
straight line velocity of over 10 µm/s). 190 
In addition, in order to perform an in-depth analysis of the evolution of sperm quality 191 
throughout the weeks of both thermal and hormonal treatments, sperm samples were 192 
classified into four classes based on the percentage of motile cells: Class I = No motile 193 
cells, II ≤ 25%, III = 25-50% and IV > 50% of motile cells. 194 
 195 
2.6 Economical analysis 196 
To analyze the economical profitability of each hormonal treatment (hCG, hCGrec and 197 
PMSG) three factors were taken into account: sperm volume, motility class and amount 198 
of hormone used. The essential aim was to relate the level of investment with 199 
the amount of good quality sperm produced using each hormonal treatment. 200 
 201 
2.7 Statistical analysis 202 
The mean and standard error were calculated for all sperm parameters (volume, density, 203 
motility and rest of kinetic parameters). Shapiro-Wilk and Levene tests were used to 204 
check the normality of data distribution and variance homogeneity, respectively. One-205 
way analysis of variance (ANOVA) and Student's t-test were used to analyze data with 206 
normal distribution. Significant differences between treatments were detected using the 207 
Tukey multiple range test (P<0.05). For non-normally distributed populations, Kruskal-208 
Wallis one-way ANOVA on ranks and Mann-Whitney U-test were used. All statistical 209 
analyses were performed using the statistical package SPSS version 19.0 for Windows 210 
software (SPSS Inc., Chicago, IL, USA). 211 
 212 
 213 
3. Results 214 
3.1 Thermal treatments 215 
With regards to the percentage of spermiating males (Figure 2A) the T10 treatment 216 
generated lower percentages (with maximum values around 70%) than the T15 and T20 217 
treatments, which reached 100% spermiating males in several weeks. In addition, T10 218 
males did not begin to produce sperm until the 10th week of treatment, whereas T20 and 219 
T15 males began spermiating earlier, in the 5th and 6th weeks, respectively. 220 
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In all the thermal treatments, there was an increasing trend in sperm volume in the first 221 
weeks of spermiation (Figure 2B). T20 males showed higher volumes than T15 and T10 222 
males in the majority of the weeks, with significant differences in the 8th and 11th week. 223 
The highest density values were observed in T20 males, with significant differences in 224 
most of the weeks (Figure 2C). Similar density patterns were observed in T20 and T15 225 
males, while T10 males showed an increase in their first three weeks of spermiation 226 
(10th to 12th week) followed by a marked decrease in the last week of the experiment 227 
(13th week). 228 
Regarding total and progressive motility (Figures 2D and 2E), T20 treatment 229 
demonstrated the highest values, reaching maximum values of 75 and 35%, respectively 230 
at week 11. From this week to the end of treatment, T20 males displayed a marked 231 
decrease in total and progressive motility. Males subjected to the T10 thermal regime 232 
showed a significant but delayed increase in motility parameters from its first 233 
spermiation week (week 10) to the end of the experiment, and ended up exceeding the 234 
values obtained with the T15 and T20 treatments due to the fact this coincided with the 235 
final reduction of motility in these treatments in the last week of treatment. 236 
The kinetic parameters (Table 1) of the sperm cells showed a similar evolution in all 237 
thermal treatments, increasing as the weeks advanced. T20 was the treatment that 238 
demonstrated the highest values in the three velocity parameters (VCL, VSL and VAP), 239 
with significant differences in several weeks.  240 
Finally, with regards to the sperm motility classes, it was observed that the T10 and T20 241 
treatments displayed better volume profiles (with relative volumes of maximum quality 242 
sperm (class IV) of 60% and 70%, respectively) than the T15 treatment, which showed 243 
values of around 50% in this same motility class (Figure 3). In addition, the T20 244 
treatment resulted in a higher number of weeks (7) with good quality samples, 245 
compared to either the T10 or T15 treatments, which only induced these good sperm 246 
samples for 3 and 5 weeks, respectively (Figure 4). 247 
 248 
3.2 Hormonal treatments 249 
PMSG treatment induced lower percentages of spermiating males (with maximum 250 
values around 50-60%) than hCG and hCGrec treatments (Figure 5A), both of which 251 
reached 100% in several weeks. In addition, PMSG males did not begin to spermiate 252 
until the 8th week of treatment, while hCG and hCGrec males began spermiating earlier, 253 
in the 5th week. 254 
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An increasing trend in sperm volume (Figure 5B) was displayed in all the hormonal 255 
treatments and hCG- and hCGrec-treated males showed higher values than PSMG-256 
treated males, with significant differences in the 10th, 11th, 14th and 18th weeks. 257 
Maximum values for PMSG, hCG and hCGrec treatments were obtained in the 15th, 19th 258 
and 20th week, respectively. 259 
Sperm density showed high variability under all the hormonal treatments (Figure 5C). 260 
Samples from males treated with hCGrec demonstrated an increase in the first 5 weeks 261 
of treatment reaching maximum values of 18 x 109, followed by a decrease from the 262 
10th week until the end of treatment. However, in the five first weeks of spermiation 263 
hCG-treated males displayed a progressive decrease and a gradual decline until the end 264 
of the treatment, reaching minimum values in the 19th week. PMSG-treated males 265 
generated the highest values at the end of the treatment, with significant differences in 266 
the 15th, 17th, 18th and 19th weeks. 267 
With regards to motile and progressive motile cells (Figuress 5D and 5E), hCGrec 268 
treatment generated the highest values, reaching maximums of 70 and 35% (motile and 269 
progressive motile cells, respectively) in the 9th week. Males treated with hCG showed a 270 
similar motility pattern to hCGrec males in the first weeks of treatment, but displayed a 271 
decrease in motile and progressive motile cells from the 11th week to the end of 272 
treatment. PMSG-treated males showed an upward trend from the 11th week, reaching 273 
motility and progressive motility values similar to hCGrec-treated males in the last 7 274 
weeks of treatment. 275 
The hCGrec and hCG treatments produced the highest values (with significant 276 
differences) in VCL, VSL and VAP throughout the first weeks of spermiation (Table 2). 277 
However, from the 14th week of treatment hCG-treated males displayed a sharp decline 278 
in these parameters, whereas values of hCGrec-treated males remained constant until the 279 
end of treatment. PMSG males showed an increasing trend over the weeks reaching 280 
values similar to those of hCGrec males in the last weeks of treatment. 281 
Finally, with regards to the sperm motility classes, hCGrec and PMSG treatments 282 
produced better volume profiles (with class IV sperm volumes around 70% and 60%, 283 
respectively) than hCG treatment, which resulted in values of less than 30% for the 284 
same motility class (Figure 6). hCGrec treatment induced good quality samples (class 285 
IV) in every week of treatment (except in the 5th week), while hCG and PMSG 286 
treatments demonstrated some weeks without good sperm samples (week 6 and 3, 287 
respectively) throughout the treatment (Figure 7). 288 
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 289 
3.3 Economical analysis 290 
The investment needed to obtain mature males was quite different in each hormonal 291 
treatment (Table 3). hCGrec treatment signified the highest investment per male and an 292 
amount of 19.5 € was necessary in order to mature each animal throughout the 21 weeks 293 
of treatment. hCG and PMSG treatments represented a smaller investment per male (7.5 294 
and 10.6 €, respectively). However, the total volume of class IV sperm obtained from 295 
hCGrec-treated males was much higher, therefore the final profitability of this hormone 296 
was the best, as it was possible to obtain one millilitre of the highest quality sperm for 297 
the lowest price (0.5 €/mL). The other hormones produced worse economic results, 298 
and PMSG was found to be the most expensive treatment (1.8 €/mL). 299 
 300 
 301 
4. Discussion 302 
4.1 Thermal treatments 303 
Temperature is one of the most important environmental factors affecting aquatic 304 
wildlife organisms, where seasonal changes in this parameter, interacting with the 305 
photoperiod signal, can regulate the sexual maturation process (Dorts et al., 2011; Van 306 
Der Kraak and Pankhurst, 1997).  307 
In terms of aquaculture production, obtaining spermiating males weeks in advance 308 
means minimising costs and risks in fish handling. In this respect, T20 males began 309 
spermiating earlier and also demonstrated higher percentages of spermiating males in all 310 
weeks, compared to the alternative thermal treatments (T15 and T10). In addition, it was 311 
observed that warm temperatures were strictly necessary in inducing sperm production 312 
in European eel males: fish that underwent both T10 and T15 thermal regimes did not 313 
begin to produce sperm until they had spent 1-2 weeks at 20 ºC. Therefore, it seems that 314 
the lower temperatures used during the first weeks of T10 and T15 treatments were 315 
capable of preventing the spermiation process and thus, the production of sperm. In a 316 
previous study about the temperature effect in the sexual maturation on the European 317 
eel, Boetius and Boetius (1967) could obtain males in an earlier stage of maturity, in 318 
which the lumen of their spermatic tubules is being filled of spermatozoa, from a wide 319 
temperature range of 13 to 25.5 ºC after 10 weeks of treatment. However, the sperm 320 
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volume obtained in this trial was not good, and a mathematical analysis of the 321 
temperature/maturation period data revealed an optimum temperature of about 20°C . 322 
In this respect, it is well known that water temperature can modulate the enzymatic 323 
activity necessary for the synthesis of steroids and its receptors and so, the different 324 
thermal treatments applied in this study could be regulating all stages of 325 
spermatogenesis and spermiogenesis throughout the gonadal development (Billard et 326 
al., 1982; Schulz and Miura, 2002; Peñaranda et al., 2011). Previous studies have 327 
demonstrated the effects of temperature on the spermatogenesis of fish: in rainbow trout 328 
(Salmo gardnierii) low temperatures stimulate the first stages of this process, while 329 
warm temperatures stimulate the latter stages (Breton and Billard, 1977); in Nile tilapia 330 
(Oreochromis niloticus) higher temperatures accelerate spermatogenesis, whereas at 331 
lower temperatures it takes longer (Vilela et al., 2003). 332 
On the other hand, parameters such as volume and density are usually analysed in sperm 333 
studies in order to report information on the amount of sperm available for use in 334 
reproductive events like artificial gamete fertilizations, etc. In the present study, the 335 
volume data agrees with values obtained by other authors of European eel studies (1-4 336 
mL 100g-1 fish; Asturiano et al., 2005, Pérez et al., 2000), and the sperm density values 337 
obtained were significantly higher than those obtained in these same experiments 338 
(values around 1-2 x109 ml-1). In this respect, it would be important to find out the 339 
minimum sperm-to-egg ratio needed for successful fertilization, but this parameter is 340 
only known for a limited number of species and few studies have been developed with 341 
regards to the European eel (Sorensen et al., unpublished results). 342 
On the other hand, total motility and progressive motility are recognized as important 343 
sperm traits for male fertility and sperm competition, because significant correlations 344 
were found between the number of motile spermatozoa and fertilization rates in some 345 
fish species (Liu et al., 2007; Ottesen et al., 2009; Rurangwa et al., 2004). In our study, 346 
T20 was the treatment that demonstrated the best values throughout most of the weeks, 347 
whereas alternative thermal regimes (T10 and T15) did not reach such high values, 348 
except for T10 males that did show values of around 70% of motile cells in the last 349 
week of treatment. Therefore, T20 was the most effective treatment with regards to 350 
these parameters (total and progressive motility), resulting in good quality samples 351 
(class IV) in almost every week of treatment, from the 5th week onwards.  352 
In addition to percentage of motile spermatozoa as a good tool to predict fertilization 353 
ability, kinetic sperm parameters (VCL, VSL or VAP) provided by CASA software 354 
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may also serve as prognostic indicators of the fertilization potential of sperm (Donnelly 355 
et al., 1998; Gage et al., 2004; Rudolfsen et al., 2008). In our study, T20 males showed 356 
higher velocity values than T15 and T10 males in most of the weeks of treatment, and 357 
VCL values were comparable with data previously reported in European eel: 134 µm/s 358 
(Gibbons et al., 1985), 160 µm/s (Woolley, 1998) or 125 µm/s (Asturiano et al., 2005). 359 
However, VSL values obtained under these thermal treatments were significantly higher 360 
than those reported in the cited literature. With VSL being one of the most important 361 
kinetic parameters (probably because spermatozoa with faster straight line speeds have 362 
more chance of contacting an oocyte in the natural environment), sperm samples 363 
induced in the present study showed better quality spermatozoa than those demonstrated 364 
in previous reproduction studies of this same species (Gibbons et al., 1985; Woolley, 365 
1998). 366 
In summary, our results demonstrate that the onset and progression of spermiation in 367 
European eel males are strongly influenced, and perhaps closely regulated, by changing 368 
water temperature. The T20 regime showed the best results in all of the sperm 369 
parameters (volume, density, motility, kinetic features, etc) throughout most weeks of 370 
treatment, becoming a reliable and productive method for inducing spermiation in this 371 
species. 372 
 373 
4.2 Hormonal treatments 374 
Our results indicate that the type of hormone used significantly affected the onset and 375 
progression of spermiation in European eel males. Recombinant hCG (hCGrec) 376 
produced the best results in almost all the sperm parameters throughout the weeks of 377 
treatment, becoming an effective and alternative treatment to that of the standard hCG 378 
used to induce the spermiation in European eel at 20 ºC. 379 
With regards to to the onset of spermiation, both hCG- and hCGrec-treated males began 380 
to produce sperm in 5th week of treatment, and both treatments induced a high 381 
percentage of spermiating males in the following weeks. Previous studies have reported 382 
similar results with this hormonal treatment both in European eel, where eel males 383 
usually begin producing sperm in the 4th-5th week of treatment (Asturiano et al., 2006; 384 
Pérez et al., 2008, Peñaranda et al., 2010a,b), and in Japanese eel, where males usually 385 
begin producing sperm in the 5th-6th week of treatment (Ohta et al., 1996, 1997). 386 
However, males induced by PMSG began to spermiate later, in the 8th week, showing a 387 
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lower percentage of spermiating males throughout all the treatment. It appears that this 388 
hormone caused a delay in the gonadal development and thus, late spermiation.  389 
These different responses found in eel males regarding the different hormonal 390 
treatments could be explained by the biological activity of each hormone. This 391 
bioactivity depends on dimerization and glycosylation, which are processes occurring in 392 
the rough endoplasmic reticulum and Golgi apparatus (Ulloa-Aguirre et al., 2001). 393 
There are different degrees and types of glycosylation, and depending on these types, 394 
gonadotropins will show more or less bioactivity (Hearn and Gomme, 2000; Ulloa-395 
Aguirre et al., 1999). In the present study, the hormones used to induce the maturation 396 
in the European eel had different characteristics and origins: hCG is a hormone 397 
produced during human pregnancy and purified from urine, while hCGrec is a 398 
recombinant version of endogenous hCG produced in Chinese hamster ovary (CHO) 399 
cultured cells by recombinant DNA technology. Both hormones (hCG and hCGrec) are 400 
analogues of the luteinizing hormone (LH). On the other hand, PMSG is a complex 401 
glycoprotein obtained from the serum of pregnant mares and acts like a follicle-402 
stimulating hormone (FSH) and luteinizing hormone (LH). Therefore, considering the 403 
different nature and origins of these hormones, it is possible that each hormone has 404 
different degrees and types of glycosylation and thus performs the stages of maturation 405 
in a different way. 406 
On the other hand, sperm volume and density are important parameters that have 407 
traditionally been used for the assessment of semen quality. Customarily, sperm volume 408 
obtained from the artificially maturated eel males has been unsuitable compared with 409 
the volume of eggs obtained from eel females (Ohta and Unuma, 2003). In this 410 
trial, milt volume increased gradually under all the treatments as the number of 411 
injections increased, probably due to the cumulative effect of hormones in the first 412 
weeks (Asturiano et al., 2005; Ohta et al., 1996; Pérez et al., 2000) and finally, due to 413 
the hydration controlled by the maturation-inducing steroids (MIS) in the last weeks 414 
(Asturiano et al., 2004b). hCGrec- and hCG-treated males showed the highest volumes 415 
throughout the treatment (>5 mL 100 g-1 fish from the 15th week onwards), 416 
exceeding previous values obtained both in European (Pérez et al., 2000) and Japanese 417 
(Ohta and Unuma, 2003) eel males. A reverse trend was evidenced in density and 418 
volume from the 10th week of treatment: as the sperm volume increased, the density 419 
values decreased. This opposite pattern may be explained by the fact that high densities 420 
are probably necessary in order to compensate for the small volumes and, in the 421 
14 
 
opposite case, low densities need to be compensated by high volumes of sperm 422 
production.  423 
On the other hand, with regards to motility and progressive motility, hCGrec was the 424 
treatment that produced the best values (both high and stable) in every week. In eel 425 
species, the potential of sperm motility is usually acquired during the period between 426 
the 7th and 9th injection (Pérez et al., 2000; Ohta and Unuma, 2003). In this trial hCGrec- 427 
and hCG-treated males showed a similar trend, while PSMG-treated males did not 428 
showed high percentages of motile cells until the 15th week. hCGrec 429 
treatmentgenerated good quality samples for the largest number of weeks, displaying 430 
samples of this kind (class IV) in almost every week of treatment. The kinetic 431 
parameters showed a similar trend to that of the motility data and hCGrec was the 432 
treatment that induced higher velocities throughout all the sampling weeks. hCG- and 433 
PMSG-treated males also showed good values in these parameters, but only at the 434 
beginning and end of treatment, respectively. 435 
Our results demonstrate that the onset and progression of spermiation in European eel 436 
males are influenced by the hormone used. In this respect, hCGrec showed the best 437 
results in all the sperm parameters (volume, density, motility, kinetic features, 438 
etc…) throughout most weeks of treatment, becoming an effective and alternative 439 
treatment to the standard hCG treatment used to induce spermiation in eel species.  440 
 441 
4.3 Economical analysis 442 
From a practical point of view, the best hormonal treatment is one which is able to 443 
provide samples with high values of volume, density, motility and kinetic 444 
parameters for as many weeks as possible. However, due to the current economic crisis, 445 
the aquaculture sector is going through a delicate situation and cheaper and more 446 
effective treatments are becoming more and more necessary. In the present 447 
study, hCGrec treatment generated the best results, improving on the results obtained by 448 
hCG hormone, which nowadays is the most widely used method of inducing male 449 
maturation in eel species. In addition, despite the greater investment 450 
required for hCGrec-treated males, the final profitability of this hormone was 451 
demonstrated to be the best, making it possible to obtain one millilitre of good quality 452 
sperm for a lower price than possible using  either of the other two hormonal treatments 453 
(hCG and PSMG). 454 
 455 
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Table legends 644 
Table 1. Kinetic parameters (VCL, VSL and VAP) of sperm cells throughout the 645 
thermal treatments (T10, T15 and T20). Data are expressed as mean (SEM) and 646 
different letters indicate significant differences between treatments. 647 
 648 
Table 2. Kinetic parameters (VCL, VSL and VAP) of sperm cells throughout the 649 
hormonal treatments (hCG, hCGrec and PMSG). Data are expressed as mean (SEM) and 650 
different letters indicate significant differences between treatments at one sampling 651 
time. 652 
 653 
Table 3. Profitability of hormonal treatments (hCG, hCGrec and PMSG) in relation to 654 
economic investment and production of high-quality (class IV) sperm. 655 
 656 
 657 
Figure legends 658 
 659 
Figure 1. Thermal regimes applied for each treatment (T10, T15 and T20). Arrows 660 
indicate the first injection with human chorionic gonadotropin (hCG).  661 
 662 
Figure 2. Evolution of sperm quality parameters throughout the temperature treatments 663 
(T10, T15 and T20): A) Percentage of spermiating males; B) Sperm volume; C) Sperm 664 
density; D) Percentage of motile cells and E) Percentage of progressive motile cells. 665 
Data are expressed as mean ± SEM and different letters indicate significant differences 666 
between treatments at each week of treatment. 667 
 668 
Figure 3. Percentage of total volume for each motility class (I-IV) in thermal 669 
treatments. Motility classes: Class I = No motile cells; II ≤ 25%; III = 25-50% and IV > 670 
50% of motile cells. 671 
 672 
Figure 4. Percentage of spermiating males from each motility class (I-IV) in each week 673 
throughout the thermal treatments: A) T10; B) T15 and C) T20. Motility classes: Class I 674 
= No motile cells; II ≤ 25%; III = 25-50% and IV > 50% of motile cells. 675 
 676 
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Figure 5. Evolution of sperm quality parameters throughout the hormonal treatments 677 
(hCG, hCGrec and PMSG): a) Percentage of spermiating males; b) Sperm volume; C) 678 
Sperm density; D) Percentage of motile cells and E) Percentage of progressive motile 679 
cells. Data are expressed as mean ± SEM and different letters indicate significant 680 
differences between treatments at each week of treatment. 681 
 682 
Figure 6. Percentage of total volume of each motility class in hormonal treatments. 683 
Motility classes: Class I = No motile cells; II ≤ 25%; III = 25-50% and IV > 50% of 684 
motile cells. 685 
 686 
Figure 7. Percentage of spermiating males from each motility class (I-IV) in each week 687 
throughout the hormonal treatments: A) hCG;  B) hCGrec and C) PMSG. Motility 688 
classes: Class I = No motile cells; II ≤ 25%; III = 25-50% and IV > 50% of motile cells.689 
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Table 1690 
 VCL  VSL  VAP 
Week T10   T15   T20   T10   T15   T20   T10   T15   T20  
5       65.5 (12.0)        25.5 (6.2)        39.6 (7.3) 
6    127.8 (43.6)  95.9 (16.2)     61.0 (31.7)  39.0 (9.2)     83.0 (37.8)  56.1 (10.4) 
7    24.1 (24.1)  77.2 (16.8)     5.4 (5.4)  27.6 (6.0)     12.1 (12.1)  43.8 (9.5) 
8    82.2 (23.5)  140.0 (9.0)     36.3 (12.3) b  63.3 (6.2) a     48.6 (14.8) b  85.7 (5.9) a 
9    85.6 (22.1) b  142.6 (9.0) a     39.9 (10.3) b  65.7 (5.3) a     53.7 (13.4) b  88.1 (5.9) a 
10 33.5 (33.5)  117.7 (20.9)  126.0 (10.8)  6.7 (6.7) b  51.2 (14.4) ab  63.9 (6.0) a  15.7 (15.7) b  69.9 (15.8) ab  83.0 (7.1) a 
11 122.1 (13.6)  122.7 (17.5)  149.9 (6.4)  49.1 (7.1)  57.5 (11.2)  72.2 (4.8)  69.8 (8.3)  76.0 (13.0)  94.3 (5.6) 
12 119.2 (9.8)  123.1 (11.4)  121.0 (8.4)  57.8 (4.7)  52.8 (9.5)  57.0 (4.2)  77.0 (6.3)  71.5 (9.5)  73.5 (5.0) 
13 133.2 (13.6) a  113.6 (12.4) ab  74.1 (5.1) b  56.4 (7.8)  49.1 (8.8)  30.2 (4.2)  79.7 (9.4) a  67.9 (9.4) ab  45.8 (3.8) b 
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Table 2 691 
 VCL  VSL  VAP 
Week hCG  hCGrec  PMSG  hCG hCGrec  PMSG  hCG     hCGrec        PMSG 
5 121.8 (0.0)  113.4 (14.1)     63.4 (0.0) 55.3 (13.7)     77.4 (0.0)  67.2 (14.1)    
6 86.5 (6.6)  108.1 (12.9)     30.4 (5.1) b 50.4 (7.1) a     49.9 (5.0)  67.5 (8.8)    
7 111.3 (14.9)  127.7 (13.2)     48.7 (7.5) 66.6 (7.1)     66.5 (9.4)  85.3 (8.6)    
8 129.7 (8.5)  141.2 (10.5)  109.1 (0.0)  60.6 (5.7) 72.5 (7.0)  50.7 (0.0)  80.9 (6.4)  91.6 (7.9)  66.5 (0.0) 
9 141.3 (18.7) ab  166.6 (4.1) a  36.5 (36.5) b  63.4 (8.5) ab 86.2 (3.9) a  14.9 (14.9) b  85.3 (11.3) a  110.9 (3.6) ab  21.9 (21.9) b 
10 96.5 (24.4) ab  147.5 (7.8) a  67.1 (29.6) b  46.3 (12.2) ab 72.3 (5.0) a  31.0 (14.7) b  59.7 (15.4) 
b 
 94.9 (5.7) a  41.2 (18.9) b 
11 119.2 (13.4) a  137.0 (7.0) a  65.9 (14.2) b  52.9 (9.2) ab 70.0 (5.4) a  31.2 (8.3) b  73.6 (10.2) a  90.6 (6.0) a  42.9 (10.4) b 
12 118.1 (5.2) ab  130.5 (10.7) a  82.0 (19.5) b  59.2 (5.5) 68.9 (6.9)  40.0 (10.9)  74.8 (5.6)  86.9 (7.8)  53.1 (13.5) 
13 112.3 (10.4) ab  145.6 (7.6) a  107.2 (10.9) b  43.9 (6.5) b 75.3 (5.7) a  48.3 (8.3) b  63.4 (7.1) b  94.9 (5.9) a  66.2 (8.8) b 
14 129.8 (9.5)  159.5 (7.2)  132.7 (12.3)  54.6 (5.0) b 76.8 (4.9) a  56.4 (6.7) ab  75.9 (6.1) b  100.9 (5.0) a  78.9 (8.0) ab 
15 71.9 (33.2) b  171.8 (7.7) a  130.0 (20.9) ab  32.2 (16.0) b 86.1 (5.8) a  57.3 (10) ab  44.2 (20.8) 
b 
 110.0 (5.9) a  80.1 (13.8) ab 
16 56.2 (34.9) b  148.3 (15.6) a  150.2 (11.4) a  26.9 (16.8) 73.6 (8.3)  68.6 (8.5)  35.7 (22.3)  95.6 (9.9)  90.8 (9.1) 
17 127.7 (16.2)  155.4 (12.8)  153.3 (8.3)  59.5 (10.4) 71.2 (7.0)  69.9 (5.3)  78.4 (11.5)  94.8 (8.4)  95.7 (6.3) 
18 108.9 (23.6)  156.4 (12.1)  133.5 (15.0)  39.6 (9.7) b 83.4 (8.9) a  59.2 (10.6) ab  60.9 (13.8) 
b 
 103.4 (9.2) a  81.2 (11.7) ab 
19 109.7 (54.9)  116.0 (15.7)  150.6 (7.8)  48.3 (26.6) 56.0 (8.2)  71.2 (5.5)  65.2 (33.8)  73.9 (10.3)  94.4 (6.5) 
20 0.0 (0.0) b  140.7 (9.5) a  123.1 (26.2) a  0.0 (0.0) b 69.2 (7.4) a  60.0 (13.8) a  0.0 (0.0) b  90.2 (7.7) a  78.1 (17.2) a 
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Table 3 692 
  hCG hCGrec PMSG 
Hormone price €/IU 0.003 0.008 0.004 
aDose price €/g treated fish 0.005 0.012 0.007 
bInvestment per male €/male 7.5 19.5 10.6 
cSperm (class IV) price €/mL 0.7 0.5 1.8 
 693 
a Hormone Price x 1.5 IU g-1 694 
b Investment to maturate one male during 21 weeks of treatment. 695 
c Total Investment / Total Volume of Sperm (class IV)  696 
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Figure 2 699 
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Figure 3 701 
Thermal treatments
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Figure 4 703 
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Figure 5 705 
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Figure 6 708 
Hormonal treatments
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Figure 7 710 
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